Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bio-Techne Corp (TECH) had Revenue of $1.22B for the most recently reported fiscal year, ending 2025-06-30.

Quarterly Annual

Figures for fiscal year ending 2025-06-30

Income Statement Financials
Revenue	$1.22B
Net Income	$73.40M
Cost of Goods Sold	$429.36M
Gross Profit	$790.27M
Operating Expenses	$1.12B
Operating Income	$102.25M
Non-Operating Income/Expense	$-3.79M
Pre-Tax Income	$98.46M
Normalized Pre-Tax Income	$98.46M
Income after Taxes	$73.40M
Income from Continuous Operations	$73.40M
Consolidated Net Income/Loss	$73.40M
Normalized Income after Taxes	$73.40M
EBIT	$102.25M
EBITDA	$212.16M
Weighted-Average Shares Outstanding (Basic)	157.52M
Weighted-Average Shares Outstanding (Diluted)	159.72M
Earnings per Share (EPS) (Basic)	$0.47
Earnings per Share (EPS) (Diluted)	$0.46
Balance Sheet Financials
Current Assets	$608.30M
Property, Plant, and Equipment	$245.72M
Long-Term Assets	$1.95B
Total Assets	$2.56B
Current Liabilities	$175.85M
Long-Term Debt	$346.00M
Long-Term Liabilities	$463.21M
Total Liabilities	$639.06M
Common Equity	$1.92B
Tangible Shareholders Equity	$572.27M
Shareholders Equity	$1.92B
Common Shares Outstanding	154.97M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$287.56M
Cash Flow from Investing Activities	$-35.18M
Cash Flow from Financial Activities	$-253.91M
Beginning Cash	$151.79M
End Cash	$162.19M
Increase/Decrease in Cash	$10.39M
Stock-Based Compensation	$40.83M
Common Stock Dividends Paid	$-50.39M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.46
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.18
Gross Margin	64.80%
Operating Margin	8.38%
EBIT Margin	8.38%
EBITDA Margin	17.40%
Pre-Tax Profit Margin	8.07%
Profit Margin	6.02%
Free Cash Flow	$256.55M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.48
Inventory Turnover	2.27
Receiveable Turnover	5.90
Days Sales in Receivables	61.91
Return on Equity	3.83%
Return on Tangible Equity	12.83%
Return on Assets	2.87%
Return on Investments	3.24%
Book Value Per Share	$12.38
Free Cash Flow per Share	$1.61
Operating Cash Flow per Share	$1.80

Data from Zacks Investment Research, Inc.